SEC Form 4 · accession 0001228621-26-000003
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joe E Kiani
Director
Period of report
Sep 23, 2026
Accepted (ET)
Sep 25, 2026 · 4:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 23, 2026 | M | 698 | — | A | 698 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Sep 23, 2026 | M | 698 | D | — | — | Common Stock | 698 | 1,397 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
- F2The reporting person received restricted stock units ("RSUs") under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on September 23, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.